Teleosis Institute to form coalition for pharmaceutical waste, disposal control
BERKELEY, Calif, A nonprofit organization wants the San Francisco Bay Area to not generate pharmaceutical waste.
The Teleosis Institute, a program of the organization Practice Greenhealth, announced Monday that it was forming a coalition of pharmacists, physicians, nurses, dentists, veterinarians and other healthcare providers to gain control of pharmaceutical waste and disposal.
“Our initiative is unique in that it catalyzes key stakeholders – the institutions that handle and dispense pharmaceuticals directly to patients and consumers – in an effort to broaden the reach of existing pharmaceutical stewardship,” Teleosis Institute senior director Joel Kreisberg said. “The San Francisco Bay Area Green Pharmacy Coalition is essentially a product stewardship program with the goal of including all players in eliminating the pollution caused by the improper disposal of unused pharmaceuticals.”
In March, the Associated Press reported that pharmaceuticals have been found in the drinking water of at least 41 million people in the United States. A number of retail pharmacy chains have started safe medication disposal initiatives to prevent pharmaceutical contamination of drinking water and diversion of medications by drug abusers.
Petrou tapped to become HHS chief of staff
WASHINGTON A former aide of former Sen. Tom Daschle will become the new chief of staff for the Department of Health and Human Services, according to published reports.
Politico reported that Laura Petrou, who worked for the South Dakota Democrat for 20 years, will start the position this week.
Mark Childress has served in the position since January. Childress also previously worked for Daschle.
Mylan announces new VP global business development
PITTSBURGH Generic drug maker Mylan announced Tuesday that it made an appointment to its executive leadership team.
Mylan appointed former Merrill Lynch investment banker Andrew Cuneo as VP global business development. The company said Cuneo is responsible for coordinating its global business development and strategic efforts.
“Drew brings a wealth of experience in the pharmaceutical, biotechnology and healthcare sectors,” Mylan vice chairman and CEO Robert Coury said in a statement. “His familiarity with our industry – and in particular with Mylan, given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”
Most recently, Cuneo served as Merrill Lynch’s director in its global healthcare investment banking group. He earned his bachelor’s degree in economics and psychology from Vanderbilt University.